Search research articles
Contact Us
Filters
Showing results (51-60 of 227) with videos related to
Page
of 23
Sort By:
International Journal of Clinical Oncology
|
June 25, 2020
Central statistical monitoring of investigator-led clinical trials in oncology
Marc Buyse, Laura Trotta, Everardo D Saad, et al.
Clinical Trials (London, England)
|
July 27, 2019
Open science: The open clinical trials data journey
Frank Rockhold, Christina Bromley, Erin K Wagner, et al.
Pharmaceutical Statistics
|
September 10, 2021
Using an interim analysis based exclusively on an early outcome in a randomized clinical trial with a long-term clinical endpoint
Leandro Garcia Barrado, Tomasz Burzykowski, Catherine Legrand, et al.
Nature Reviews. Clinical Oncology
|
February 8, 2017
Precision medicine needs randomized clinical trials
Everardo D Saad, Xavier Paoletti, Tomasz Burzykowski, et al.
Pancreas
|
January 11, 2019
The Benefit-Risk Balance of Nab-Paclitaxel in Metastatic Pancreatic Adenocarcinoma
Julien Péron, Joris Giai, Delphine Maucort-Boulch, et al.
BMJ Open
|
October 17, 2025
Regional variation in clinical-trial risks: a large-scale analysis of 585 clinical trials
Sylviane de Viron, Steve Young, Laura Trotta, et al.
International Journal of Clinical Oncology
|
January 14, 2018
Meta-analysis of randomized clinical trials in the era of individual patient data sharing
Takuya Kawahara, Musashi Fukuda, Koji Oba, et al.
Biometrics
|
August 16, 2011
Predicting treatment effect from surrogate endpoints and historical trials: an extrapolation involving probabilities of a binary outcome or survival to a specific time
Stuart G Baker, Daniel J Sargent, Marc Buyse, et al.
The New England Journal of Medicine
|
October 16, 2014
Data sharing, year 1--access to data from industry-sponsored clinical trials
Brian L Strom, Marc Buyse, John Hughes, et al.
Lifetime Data Analysis
|
January 22, 2008
Exploring and validating surrogate endpoints in colorectal cancer
Tomasz Burzykowski, Marc Buyse, Greg Yothers, et al.
Page
of 23
Search research articles
Search
Showing results (51-60 of 227) with videos related to
Sort By:
Page
of 23
International Journal of Clinical Oncology
|
June 25, 2020
Central statistical monitoring of investigator-led clinical trials in oncology
Marc Buyse, Laura Trotta, Everardo D Saad, et al.
Clinical Trials (London, England)
|
July 27, 2019
Open science: The open clinical trials data journey
Frank Rockhold, Christina Bromley, Erin K Wagner, et al.
Pharmaceutical Statistics
|
September 10, 2021
Using an interim analysis based exclusively on an early outcome in a randomized clinical trial with a long-term clinical endpoint
Leandro Garcia Barrado, Tomasz Burzykowski, Catherine Legrand, et al.
Nature Reviews. Clinical Oncology
|
February 8, 2017
Precision medicine needs randomized clinical trials
Everardo D Saad, Xavier Paoletti, Tomasz Burzykowski, et al.
Pancreas
|
January 11, 2019
The Benefit-Risk Balance of Nab-Paclitaxel in Metastatic Pancreatic Adenocarcinoma
Julien Péron, Joris Giai, Delphine Maucort-Boulch, et al.
BMJ Open
|
October 17, 2025
Regional variation in clinical-trial risks: a large-scale analysis of 585 clinical trials
Sylviane de Viron, Steve Young, Laura Trotta, et al.
International Journal of Clinical Oncology
|
January 14, 2018
Meta-analysis of randomized clinical trials in the era of individual patient data sharing
Takuya Kawahara, Musashi Fukuda, Koji Oba, et al.
Biometrics
|
August 16, 2011
Predicting treatment effect from surrogate endpoints and historical trials: an extrapolation involving probabilities of a binary outcome or survival to a specific time
Stuart G Baker, Daniel J Sargent, Marc Buyse, et al.
The New England Journal of Medicine
|
October 16, 2014
Data sharing, year 1--access to data from industry-sponsored clinical trials
Brian L Strom, Marc Buyse, John Hughes, et al.
Lifetime Data Analysis
|
January 22, 2008
Exploring and validating surrogate endpoints in colorectal cancer
Tomasz Burzykowski, Marc Buyse, Greg Yothers, et al.
Page
of 23